[1]中华医学会.酒精性肝病诊断标准[J].中华肝脏病杂志, 2001, 9 (5) :264.
|
[2] 戴德银.实用新药物手册[M].北京:人民军医出版社, 2002:845-847.
|
[3]Gutierrez-Ruiz MC, Bucio L, Correa A, et al.Metadoxineprevent damage produced by ethanol and acetaldehyde inhepatocyte and hepatic stellate cells in culture[J].Pharma-col Res, 2001, 44 (4) :431-436.
|
[4]Diaz Martinez MC, Diaz Martinez A, Villamil Salcedo V, et al.Efficacy of metadoxine in the management of acute alcoholintoxication[J].J Int Med Res, 2002, 30 (1) :44-51.
|
[5]Shpilenya LS, Muzychenko AP, Gasbarrini G, et al.Meta-doxine in acute alcohol intoxication:a double-blind, ran-domized, placebo-controlled study[J].Alcohol Clin ExpRes, 2002, 26 (3) :340-346.
|
[6]Addolorato G, Ancona C, Capristo E, et al.Metadoxine inthe treatment of acute and chronic alcoholism:a review[J].Int J Immunopathol Pharmacol, 2003, 16 (3) :207-214.
|
[7]杨卫红.还原型谷胱甘肽联合硫普罗宁治疗药物性肝炎43例的疗效观察[J].广东医学院学报, 2006, 24 (6) :621-622.
|
[8]张武汉.硫普罗宁治疗酒精性肝炎56例[J].实用肝脏病杂志, 2006, 9 (4) :235.
|
[9]吕明磊, 刘琴, 李旭东, 等.硫普罗宁注射剂与HD-91-Ⅱ型肝病治疗仪联合治疗脂肪肝临床观察[J].医学信息手术学分册, 2007, 20 (4) :327-328.
|
[10]汪索文, 周世庆, 张伯新, 等.美他多辛治疗酒精性肝病的疗效观察[J].中国全科医学, 2005, 8 (10) :835.
|
[11]茅益民, 曾民德, 陆伦根, 等.美他多辛治疗酒精性肝病的多中心、随机、双盲、安慰剂平行对照临床研究[J].肝脏, 2006, 11 (5) :303-306.
|